Search research articles
Contact Us
Filters
Showing results (131-140 of 268) with videos related to
Page
of 27
Sort By:
Neuro-Oncology Advances
|
April 23, 2025
Outcomes in patients with multiple sclerosis and solid organ cancers treated with immune checkpoint inhibitors
Chanawee Hirunpattarasilp, Pingfu Fu, Seunghee Park Margevicius, et al.
Experimental Dermatology
|
December 29, 2017
Characterization of the facial microbiome in twins discordant for rosacea
Asifa K Zaidi, Katrina Spaunhurst, Daniel Sprockett, et al.
Journal of Clinical Immunology
|
March 20, 2004
Deficient IFN-gamma expression in umbilical cord blood (UCB) T cells can be rescued by IFN-gamma-mediated increase in NFATc2 expression
Suzanne Kadereit, Gwendolyn R Junge, Thomas Kleen, et al.
Leukemia & Lymphoma
|
October 6, 2007
Antiangiogenic activity of thalidomide in combination with fludarabine, carboplatin, and topotecan for high-risk acute myelogenous leukemia
Paul Barr, Pingfu Fu, Hillard Lazarus, et al.
Science Advances
|
November 25, 2022
A tumor vasculature-based imaging biomarker for predicting response and survival in patients with lung cancer treated with checkpoint inhibitors
Mehdi Alilou, Mohammadhadi Khorrami, Prateek Prasanna, et al.
Scientific Reports
|
May 15, 2024
Enhancing cardiovascular risk prediction through AI-enabled calcium-omics
Ammar Hoori, Sadeer Al-Kindi, Tao Hu, et al.
Investigational New Drugs
|
March 13, 2014
Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer
Anita Schwandt, Vivian E von Gruenigen, Robert M Wenham, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 3, 2007
Phase II trial of thalidomide as maintenance therapy for extensive stage small cell lung cancer after response to chemotherapy
Afshin Dowlati, Shanmuga Subbiah, Matthew Cooney, et al.
Clinical Lung Cancer
|
November 22, 2023
The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic Radiation Therapy for Extensive Stage Small-Cell Lung Cancer in the Transition to the Chemo-Immunotherapy Era: A Single Institution Series
Andrew J Gross, Saad Sheikh, Michael Kharouta, et al.
NPJ Precision Oncology
|
June 2, 2023
CT radiomic signature predicts survival and chemotherapy benefit in stage I and II HPV-associated oropharyngeal carcinoma
Bolin Song, Kailin Yang, Vidya Sankar Viswanathan, et al.
Page
of 27
Search research articles
Search
Showing results (131-140 of 268) with videos related to
Sort By:
Page
of 27
Neuro-Oncology Advances
|
April 23, 2025
Outcomes in patients with multiple sclerosis and solid organ cancers treated with immune checkpoint inhibitors
Chanawee Hirunpattarasilp, Pingfu Fu, Seunghee Park Margevicius, et al.
Experimental Dermatology
|
December 29, 2017
Characterization of the facial microbiome in twins discordant for rosacea
Asifa K Zaidi, Katrina Spaunhurst, Daniel Sprockett, et al.
Journal of Clinical Immunology
|
March 20, 2004
Deficient IFN-gamma expression in umbilical cord blood (UCB) T cells can be rescued by IFN-gamma-mediated increase in NFATc2 expression
Suzanne Kadereit, Gwendolyn R Junge, Thomas Kleen, et al.
Leukemia & Lymphoma
|
October 6, 2007
Antiangiogenic activity of thalidomide in combination with fludarabine, carboplatin, and topotecan for high-risk acute myelogenous leukemia
Paul Barr, Pingfu Fu, Hillard Lazarus, et al.
Science Advances
|
November 25, 2022
A tumor vasculature-based imaging biomarker for predicting response and survival in patients with lung cancer treated with checkpoint inhibitors
Mehdi Alilou, Mohammadhadi Khorrami, Prateek Prasanna, et al.
Scientific Reports
|
May 15, 2024
Enhancing cardiovascular risk prediction through AI-enabled calcium-omics
Ammar Hoori, Sadeer Al-Kindi, Tao Hu, et al.
Investigational New Drugs
|
March 13, 2014
Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer
Anita Schwandt, Vivian E von Gruenigen, Robert M Wenham, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 3, 2007
Phase II trial of thalidomide as maintenance therapy for extensive stage small cell lung cancer after response to chemotherapy
Afshin Dowlati, Shanmuga Subbiah, Matthew Cooney, et al.
Clinical Lung Cancer
|
November 22, 2023
The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic Radiation Therapy for Extensive Stage Small-Cell Lung Cancer in the Transition to the Chemo-Immunotherapy Era: A Single Institution Series
Andrew J Gross, Saad Sheikh, Michael Kharouta, et al.
NPJ Precision Oncology
|
June 2, 2023
CT radiomic signature predicts survival and chemotherapy benefit in stage I and II HPV-associated oropharyngeal carcinoma
Bolin Song, Kailin Yang, Vidya Sankar Viswanathan, et al.
Page
of 27